,

פרופ. אנדרו בלאוולט

Andy Blauvelt is President and Owner of Oregon Medical Research Center in Portland, Oregon. He received his undergraduate degree in Electrical Engineering at Purdue University, his medical degree at Michigan State University, and his Healthcare MBA from Portland State University/Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in basic immunology at the National Institutes of Health (NIH). He has held senior staff positions at the NIH, OHSU, and the Portland VA Medical Center. Andy’s clinical and research expertise is in immunology, virology, psoriasis, atopic dermatitis, and biologic therapies for complex medical dermatology patients, having published over 230 papers and spoken across the world on these topics. Dr. Blauvelt is an elected member of the American Society for Clinical Investigation (a leading society for physician-scientists) and the International Psoriasis Council (the premier group of psoriasis experts in the world)

TITLE OF LECTURES
> il-23 inhibitors, from clinical data to clinical experience
> Role of IL-23 in psoriasis pathogenesis

 

The Lecture is Sponsored by